474 — Aceso Life Science Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Aceso Life Science, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	581	786	717	602	469
Net Total Accounts Receivable
Net Total Receivables	914	756	1,065	744	775
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,634	2,026	2,266	2,297	1,265
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	411	291	283	281	234
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	5,033	6,165	6,263	6,301	4,786
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,049	1,096	2,451	2,855	2,214
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,543	3,783	4,261	4,752	3,865
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	2,490	2,382	2,002	1,549	921
Total Liabilities & Shareholders' Equity	5,033	6,165	6,263	6,301	4,786
Total Common Shares Outstanding